MeSH D062787 - drug overdose
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D063487:Prescription drug misuse
0 Companies
0 Drugs
Success rate
D062787:
Drug overdose
D000083682:Opiate overdose
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Purdue Pharma | Nalmefene | Nalmefene | 2022-02-08 | |||
| Hikma Pharmaceuticals | Nalmefene | Revex | 1995-04-17 | |||
| Lundbeck | Nalmefene | Selincro | 2013-02-24 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
50%1/2
Phase 3
100%6/6
Approved: 6Overall Success rate: 33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use